Get the Stockscreener App
0.4539
2.01%
-0.0093
After Hours:
.47
0.0161
+3.55%
Bionano Genomics Inc stock is traded at $0.4539, with a volume of 1.44M.
It is down -2.01% in the last 24 hours and down -7.37% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
See More
Previous Close:
$0.4632
Open:
$0.4705
24h Volume:
1.44M
Relative Volume:
0.82
Market Cap:
$39.15M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.0284
EPS:
-16.0015
Net Cash Flow:
$-126.87M
1W Performance:
+13.48%
1M Performance:
-7.37%
6M Performance:
-59.11%
1Y Performance:
-85.02%
1-Day Range:
$0.4412
$0.48
1-Week Range:
$0.3904
$0.5086
52-Week Range:
$0.3055
$3.03
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Short Interest in Bionano Genomics, Inc. (NASDAQ:BNGO) Declines By 13.0% - Defense World
Bionano Genomics Inc (BNGO) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Are Value Hunters Buying Bionano Genomics Inc (NASDAQ: BNGO) Stock? - Stocks Register
It would be worthwhile to take a closer look at Bionano Genomics Inc (BNGO) - US Post News
Bionano Genomics Inc (BNGO) Stock: From Low to High in 52 Weeks - The InvestChronicle
Ratios Reveal: Breaking Down Bionano Genomics Inc (BNGO)’s Financial Health - The Dwinnex
BTIG downgrades Bionano to Neutral after fourth workforce reduction - MSN
BTIG downgrades Bionano Genomics stock to Neutral amid workforce cuts By Investing.com - Investing.com Australia
BTIG Downgrades Bionano Genomics (BNGO) - MSN
BTIG downgrades Bionano Genomics stock to Neutral amid workforce cuts By Investing.com - Investing.com Canada
BTIG downgrades Bionano Genomics stock to Neutral amid workforce cuts By Investing.com - Investing.com UK
BioNano Genomics Restructures for Cost Efficiency and Cash Flow Optimization - TipRanks
Should investors be concerned about Bionano Genomics Inc (BNGO)? - US Post News
Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now - Zacks Investment Research
Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now - Yahoo Finance
Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference - StockTitan
Bionano Genomics, Inc. (NASDAQ:BNGO) Short Interest Update - Defense World
Many Still Looking Away From Bionano Genomics, Inc. (NASDAQ:BNGO) - Simply Wall St
Bionano Genomics (NASDAQ:BNGO) Receives Sector Perform Rating from Scotiabank - Defense World
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why - MSN
BNGO (Bionano Genomics) Cash Flow from Discontinued Operati - GuruFocus.com
Bionano Genomics (FRA:2Y30) EPS (Basic) : €-3.02 (TTM As of Jun. 2024) - GuruFocus.com
BNGO (Bionano Genomics) Enterprise Value : $54.67 Mil (As of Aug. 19, 2024) - GuruFocus.com
Bionano Genomics (STU:2Y30) Revenue : €33.85 Mil (TTM As of Jun. 2024) - GuruFocus.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Short Interest Down 7.1% in July - Defense World
Price T Rowe Associates Inc. MD Acquires 38,900 Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano Genomics (FRA:2Y30) Cash Conversion Cycle : 264.44 (As of Jun. 2024) - GuruFocus.com
BNGO (Bionano Genomics) Quick Ratio : 1.11 (As of Jun. 2024) - GuruFocus.com
Bionano Genomics (STU:2Y30) EV-to-Revenue : 1.47 (As of Aug. 18, 2024) - GuruFocus.com
BNGO (Bionano Genomics) 6-1 Month Momentum % : -47.26% (As of Aug. 17, 2024) - GuruFocus.com
Bionano Genomics (STU:2Y30) 5-Year EBITDA Growth Rate : 26.90% (As of Jun. 2024) - GuruFocus.com
BNGO (Bionano Genomics) 5-Year Yield-on-Cost % : 0.00 (As of Aug. 18, 2024) - GuruFocus.com
BTIG maintains Buy rating on Bionano Genomics shares, cites CPT code from AMA - Investing.com Australia
BTIG maintains Buy rating on Bionano Genomics shares, cites CPT code from AMA - Investing.com
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why - Yahoo Finance
Virtu Financial LLC Acquires Shares of 32,883 Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Earnings call: Bionano sees decline in Q2 revenue, eyes cost cuts - Investing.com
Bionano Genomics, Inc. (NASDAQ:BNGO) Q2 2024 Earnings Call Transcript - Insider Monkey
Bionano Genomics Inc’s Shares Reel: -54.88% Quarterly Revenue Decline Amid 29.83M Market Cap - The InvestChronicle
Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript - AOL
The Globe and Mail - The Globe and Mail
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace
BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024 - MSN
Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript - Seeking Alpha
Bionano Genomics stock hits 52-week low at $0.5 - Investing.com
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress - wallstreet:online
Upcoming Opportunities in High-Resolution Genomic Mapping - openPR
It makes sense and dollars to buy Bionano Genomics Inc (BNGO) stock - SETE News
Market Recap: Bionano Genomics Inc (BNGO)’s Negative Momentum, Closing at 0.55 - The Dwinnex
Bionano Genomics (BNGO) to Release Earnings on Wednesday - Defense World
Bionano Genomics, Inc. (NASDAQ:BNGO) Shares Sold by Quadrature Capital Ltd - Defense World
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):